Sagent Pharma signs development agreement with Chongqing Lummy
China-based Chongqing Lummy is engaged in research, development, manufacture and sale of anti-infective, oncology and nutritional parenteral products. With this agreement, Sagent intends to strengthen its presence in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.